PACB icon

Pacific Biosciences

94 hedge funds and large institutions have $230M invested in Pacific Biosciences in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
-7
Holders Change %
-6.93%
% of All Funds
2.51%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
13
Increased
32
Reduced
29
Closed
19
Calls
$107K
Puts
$162K
Net Calls
-$55K
Net Calls Change
-$342K
Name Holding Trade Value Shares
Change
Shares
Change %
Citadel Advisors
101
Citadel Advisors
Florida
-$327K -41,659 Closed
CIA
102
Capital Impact Advisors
Massachusetts
-$207K -26,437 Closed
PP
103
Paloma Partners
Connecticut
-$180K -22,900 Closed
Squarepoint
104
Squarepoint
New York
-$176K -22,400 Closed
William Blair & Company
105
William Blair & Company
Illinois
-$164K -21,000 Closed
SG Americas Securities
106
SG Americas Securities
New York
-$122K -15,603 Closed
LTFS
107
Ladenburg Thalmann Financial Services
Florida
-$110K -14,000 Closed
EMG
108
Ellington Management Group
Connecticut
-$78K -10,000 Closed
GT
109
Glenmede Trust
Pennsylvania
-$54K -7,000 Closed
FNBT
110
FineMark National Bank & Trust
Florida
-$55K -7,000 Closed
QT
111
Quantbot Technologies
New York
-$32K -4,097 Closed
PCM
112
Prelude Capital Management
New York
-$26K -3,256 Closed
TRCT
113
Tower Research Capital (TRC)
New York
-$2K -200 Closed